News Analysis
German health minister’s ‘locust’ sponsor comments spook live healthcare deals – market sources
- New investors scared by minister’s remarks on limiting outpatient profit
- Rush to consolidate and buy ‘plan hospitals’ before any new laws
- Small clinics with succession problems hurry to exit
Startups struggling to raise capital in Mexico could find a new source of funding if planned securities bill is approved - Analysis
- Bill seeks to streamline public offerings
- Startups primed to take advantage
- Last Mexican IPO in 2020
- PEs look to adapt the traditional auction format to more flexible processes
- Exits in Europe at decade low amid debt financing drought and macro woes
- Bilateral talks, all-equity tickets, minority stakes, continuation funds on rise
South Korea’s ramped up FDI regulation hinders Chinese semiconductor and biotechnology M&A attempts
- NASIA strengthens existing FDI regulation of ‘national core technologies’
- Chinese investments in sensitive sectors face deep scrutiny, longer reviews
- Cowin DST suitor Focuslight expects to hear from MOTIE in February
- Ramped up FDI screening comes after government found over 100 tech leakages
- Innovation, price and complaints key factors for Art 22
- Horizon/Amgen bullish on regulatory clearances
- Biologics portfolios cover similar therapeutic areas with no obvious overlaps
China CAC’s cybersecurity reviews of overseas IPOs typically lead to three outcomes – sources
- "No compelling reason to initiate review" verdict most frequently seen
- Some cases require "rectification" prior to approval
- No specific criteria for deals to enter "substantial review"
- US listings remain more popular than Swiss offerings despite stricter reviews
DOJ focus on Interlocking directorates reflects ‘shot across the bow’ at PE – Analysis
- Holders of board seats on competing firms scrutinized amid coordination fears
- Move reflects Antitrust Division’s concern about market power of large PE funds
- New enforcement likely to drive increased Section 8 compliance checks–lawyers
- More structured transactions expected to prevent potential valuation drops
- ‘Patient’ strategics poised to pounce
Confirm cancellation
Something went wrong.
An error occurred trying to play the stream. Please reload the page and try again.
CloseSign-up to join the ION Analytics Community to:
- Register for events
- Access market insights
- Download reports